As the leader of the Group Benefits Product Leadership Team, Jean-Michel is responsible for the creation and execution of the Group Benefits (GB) product strategy to differentiate Sun Life as the leading benefits provider in Canada. His focus on innovation, which includes finding new approaches to product development, has brought better and faster solutions to our clients. He also provides strategic leadership and insights when representing GB on industry task forces and government relations activities that have positively influenced our business. Product development directors along with their teams based in Montreal, Toronto and Waterloo report to him.
Jean-Michel has made significant contributions to the product strategy including innovations in high-cost drug strategy, the launch of new solutions such as virtual/cognitive behaviour therapy and the introduction of pharmacogenetics. JM joined Sun Life as Director, Pharmaceutical Benefits in 2013 following a number of years in the pharmaceutical industry, including practicing as a Pharmacist and as a Marketing Brand Manager for a large pharmaceutical manufacturer. He obtained his Bachelor of Pharmacy degree from the University of Montreal, followed by Post Graduate Studies at the University of Montpellier, France, and a MBA from McGill University.
Jean-Michel Lavoie has been nominated as one of 2017 LIMRA’s 25 Rising Stars in Innovation. The contest recognizes up-and-coming leaders under 40 amongst the organisation’s 850 member companies. In 2018, the Journal de l’assurance highlighted him as one of the Top 25 New Leaders in insurance for his work and involvement in the industry.
Jean-Michel is involved with the McCord Museum and sits on the Board of Directors for the Professional Liability Insurance Fund of Pharmacists and Drug Free Kids Canada. |